1. What Is Red Light Therapy for Depression, and Is It Real?
Quick Answer: Yes — red light therapy for depression is backed by a growing body of clinical evidence. When near-infrared light is applied transcranially (to the skull), it penetrates brain tissue, boosts mitochondrial energy in neurons, reduces neuroinflammation, and promotes neuroplasticity — all biological pathways directly linked to mood disorders.
Depression is one of the most common and debilitating conditions I see in people who come to us looking for answers beyond what conventional medicine has offered them. According to the World Health Organization, over 280 million people worldwide live with depression, and many do not get the relief they need from antidepressant medication alone. That gap is one of the reasons we believe therapies like red light therapy deserve a closer look.
More specifically, we are talking about transcranial photobiomodulation, or t-PBM. This involves the application of red and near-infrared light directly to the scalp and forehead, allowing wavelengths to penetrate the skull and reach the brain’s prefrontal cortex. This area of the brain plays an important role in mood regulation, decision-making, and emotional processing.
people worldwide affected by depression (WHO)
response rates across PBM depression studies
nm — most studied wavelength for transcranial PBM
RCTs included in the landmark 2024 meta-analysis
2. How Does Red Light Therapy Affect the Brain?
The mechanism is the same one we use throughout our red light protocols, but in this case, it is applied specifically to the brain. Near-infrared light at wavelengths of 810–830nm can penetrate the skull and is absorbed by cytochrome c oxidase (CCO) in neuronal mitochondria. This is the same enzyme we discuss in more detail in our article on red light therapy for vision. The difference here is the target tissue: instead of retinal cells, we’re energizing neurons in the prefrontal cortex.
The Brain-Specific Cascade
- Mitochondrial boost — Enhanced ATP production in neurons of the prefrontal cortex, the brain region most involved in mood regulation
- Reduced neuroinflammation — PBM lowers pro-inflammatory cytokines linked to major depressive disorder (MDD)
- Neuroplasticity — Stimulates BDNF (brain-derived neurotrophic factor), which supports new neural connections — the same pathway targeted by antidepressants
- Improved cerebral blood flow — Increased oxygenation to the prefrontal cortex improves mood regulation and executive function
- Endogenous opioid modulation — PBM may influence the brain’s natural opioid system, contributing to improved mood and reduced emotional pain
What I find particularly compelling is that these mechanisms directly parallel what we know causes depression. A 2025 comprehensive review in Theranostics (Wang et al.) found that PBM targets key upstream pathways linked to depression, including mitochondrial dysfunction, oxidative stress, and neuroinflammation. In other words, this is not just a vague “feel good” effect. It is a biological process with a clear mechanism behind it.
The 2024 brain PBM review published in Cells by Nairuz et al. also points to evidence that transcranial PBM may support brain network connectivity and promote neurogenesis. These mechanisms overlap with some of the pathways targeted by leading antidepressant medications, but without the same systemic side effect profile.
3. What Does the Clinical Evidence Actually Say?
This is the question we hear most often, and it is the right one to ask.
Here is what the evidence shows, from individual trials to the most recent meta-analysis.
Major Depressive Disorder (MDD)
Multiple RCTs, including the ELATED-2 and ELATED-3 trials from Harvard/MGH, show significant reductions in depression scores using transcranial near-infrared PBM.
Seasonal Affective Disorder (SAD)
Red and near-infrared light therapy shows consistent benefit for SAD, supporting circadian rhythm regulation and serotonin production.
Treatment-Resistant Depression
Early evidence suggests t-PBM may offer benefit as an adjunctive therapy for patients who haven’t responded to antidepressant medication.
Postpartum Depression
Emerging studies suggest PBM’s anti-inflammatory and neuroplasticity-promoting effects may support postpartum mood recovery.
Bipolar Depression
Preclinical and early clinical data suggest PBM may help stabilize mood in bipolar disorder by targeting mitochondrial dysfunction.
Anxiety Co-morbid with Depression
A 2019 pilot study showed transcranial PBM reduced symptoms in generalized anxiety disorder, which frequently co-occurs with depression.
The ELATED Trials — Harvard & Massachusetts General Hospital
The research that changed how I talk about this with members came from a series of trials run at Massachusetts General Hospital and Harvard Medical School. The ELATED-2 pilot trial (Cassano et al., 2018) was a double-blind, sham-controlled study testing transcranial near-infrared PBM (823nm) on patients with major depressive disorder. The results showed meaningful reductions in HAM-D17 depression scores, which is a validated clinical measure, with no significant adverse effects reported.
Building on those findings, the ELATED-3 multicenter randomized sham-controlled trial (Iosifescu et al., 2022) scaled the research across multiple sites and confirmed the antidepressant effects of very low-level transcranial PBM. The fact that Harvard psychiatrists and the Nathan Kline Institute put serious resources behind this tells me everything I need to know about where this research is heading.
The 2024 Meta-Analysis — The Strongest Evidence Yet
For me, the most significant development in this space came with the 2024 systematic review and meta-analysis by Ji et al. in Frontiers in Psychiatry. The researchers pooled data from 11 randomized controlled trials — 3,265 studies screened — and the forest plot results were clear: PBM significantly alleviated depression symptoms (SMD = −0.55, 95% CI [−0.75, −0.35]). That’s a clinically meaningful effect size, comparable to some antidepressant medications, but without the systemic side effects. This is the study I now share with every skeptic who walks through our door.
4. Red Light Therapy vs. Antidepressants: A Complement, Not a Replacement
I want to be very direct about this because I think it matters: we never position red light therapy as a replacement for prescribed antidepressant medication or professional psychiatric care. What the evidence supports is its use as a helpful adjunctive therapy, meaning something that can work alongside conventional treatment to support better outcomes.
Several of our members who use red light therapy for mood support have shared that it helps them get more out of their existing treatment. They often mention better sleep, more energy, less brain fog, and a greater sense of emotional stability.
These are exactly the outcomes the ELATED trials were measuring, and they’re consistent with what the biology predicts.
Important Safety Notice
If you are currently managing depression with medication or under the care of a psychiatrist or psychologist, always consult your healthcare provider before adding red light therapy to your routine. Never stop or reduce prescribed medication without professional guidance.
5. Recommended Protocol for Mood & Mental Health
Based on the clinical literature and our own practice, here are the parameters we use for members targeting mood and mental health support:
NM WAVELENGTH
MINS PER SESSION
PER WEEK
APPLICATION AREA
Where to Apply the Light
Unlike protocols for skin or joints, transcranial PBM for depression focuses on the prefrontal cortex, which is the front part of the brain just behind the forehead.
Clinical trials typically position the device over the forehead and/or the temples, allowing near-infrared light to penetrate the skull and reach the underlying cortical tissue. This is a very different application than general body panels, and device selection matters.
Consistency Over Intensity
In my experience, members who see the best mood-related results are those who stick with a consistent daily or near-daily routine for at least 4–8 weeks. The neuroplasticity effects build over time as mood-related neural pathways begin to adapt and change.
Think of it like exercise for the brain: one session won’t transform anything, but six weeks of consistent sessions can produce meaningful, measurable change.
Ready to build your protocol? Visit our page on how to benefit the most from red light therapy — including session tips, what to expect, and how to maximise every visit.
6. Frequently Asked Questions
Can red light therapy actually treat depression?
The clinical evidence shows it can significantly reduce depression symptoms, particularly as an adjunctive therapy. A 2024 meta-analysis of 11 RCTs confirmed a meaningful effect size. I would describe it as a biologically grounded tool that supports some of the deeper processes linked to depression, including neuroinflammation, mitochondrial function, and neuroplasticity, rather than only focusing on symptom management.
What wavelength is used for depression?
The most studied wavelengths for transcranial photobiomodulation are 810–830nm, which sit in the near-infrared range. These wavelengths penetrate the skull effectively and are well absorbed by cytochrome c oxidase in brain neurons. This is different from the 630–670nm wavelengths we use for skin and eye protocols.
How long does it take to see results?
In our experience, most members report subtle improvements in energy and mood within 2–4 weeks, with more significant changes emerging at the 6–8 week mark. Clinical trials typically measure outcomes at 8–12 weeks. Consistency is key. This is not a one-session solution.
Is red light therapy safe for depression?
Yes — the clinical trials conducted to date, including the ELATED series from Harvard/MGH, have reported no significant adverse effects from transcranial PBM. It is non-invasive, drug-free, and does not interact with most medications. That said, always consult a healthcare provider before beginning, especially if you are managing a serious mental health condition.
Can it help with seasonal affective disorder (SAD)?
Yes — and this is one of the strongest use cases. SAD is closely linked to light deprivation and disrupted circadian rhythms. Red and near-infrared light therapy supports serotonin production and circadian regulation in ways that complement existing light therapy protocols. We recommend it as part of a broader seasonal wellness approach for members who struggle in winter months.
Can red light therapy replace antidepressants?
No — and we never recommend it as a replacement. What the research supports is its use alongside conventional care. Several members have told us that incorporating red light therapy helped them feel the positive effects of their medication more fully. Speak with your doctor before making any changes to your treatment plan.
Related Reading
If you found this article helpful, you may also be interested in our in-depth guide on a closely related topic:
→ Can Red Light Therapy Really Improve Your Vision? Here's What We Know — Covers the same photobiomodulation mechanisms applied to retinal health, macular degeneration, myopia, and age-related vision decline.
Related Reading → Can Red Light Therapy Really Improve Your Vision? Here’s What We Know — Our in-depth guide to photobiomodulation for retinal health, macular degeneration, and age-related vision decline.
References
The following peer-reviewed studies and authoritative sources directly informed the content of this article:
- Ji Q. et al. — Photobiomodulation improves depression symptoms: systematic review & meta-analysis. Frontiers in Psychiatry, 2024
- Wang L. et al. — Photobiomodulation: shining a light on depression. Theranostics, 2025
- Cassano P. et al. — Transcranial PBM for Major Depressive Disorder: The ELATED-2 Pilot Trial. PMC, 2018
- Iosifescu D.V. et al. — The ELATED-3 Multicenter, Randomized, Sham-Controlled Trial. PubMed, 2022
- Nairuz T. et al. — Photobiomodulation Therapy on Brain: Cognitive Dynamics. Cells, 2024
- World Health Organization — Depression Fact Sheet
- National Institute of Mental Health — Depression Overview
- PubMed — Transcranial Photobiomodulation Depression (full search)
This article is for informational purposes only and does not constitute medical advice. If you are experiencing depression or any mental health condition, please consult a qualified healthcare professional. Never discontinue prescribed medication without medical guidance.
